Residual edema evaluation with ranibizumab 0.5 mg and 2.0 mg formulations for diabetic macular edema (REEF study) - Concepedia

Concepedia

Publication | Open Access

Residual edema evaluation with ranibizumab 0.5 mg and 2.0 mg formulations for diabetic macular edema (REEF study)

DOI Full Paper Access

37

Citations

36

References

2015

Year

Dilsher S. Dhoot, Dante J. Pieramici, Ma'an Nasir, Alessandro Castellarin, Steve Couvillion, Robert F. See, Nathan Steinle, M. D. Bennett, Melvin Rabena, Robert L. Avery

Diabetic RetinopathyOcular DiseaseOphthalmologyMedicineDiabetesEye HealthReef StudyGlaucomaResidual Edema EvaluationPharmacologyMg Formulations

References

	Year	Citations

Page 1

Page 1